Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00050232
Status:
COMPLETED
Last Update Posted:
2016-07-14
First Post:
2002-12-02
Brief Title:
Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients
Sponsor:
Avanir Pharmaceuticals
Organization:
Avanir Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-12
Start Date Type:
None
Primary Completion Date:
2004-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-06
Completion Date Type:
ACTUAL
First Submit Date:
2002-12-02
First Submit QC Date:
December 2 2002
Study First Post Date:
2002-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-07-13
Last Update Post Date:
2016-07-14
Last Update Post Date Type:
ESTIMATED